Source: International Congress 2016 – Airway pharmacology: drug targets and mode of action
Disease area: Airway diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Irene Heijink (Groningen, Netherlands), H. Irene Heijink, Marnix Jonker, Dirkje S. Postma, Maarten van den Berge. Budesonide and fluticasone propionate exertdifferential effects on human bronchial epithelial cells exposed to streptococcus pneumoniae and viral mimetic. Eur Respir J 2016; 48: Suppl. 60, 5061

Member's Comments

No comment yet.

Related content which might interest you: Differential effects of budesonide and fluticasone propionate on immune defense genes in human bronchial epithelium Source: International Congress 2015 – The immunology of allergic airway disease Year: 2015 Differential effects of budesonide and fluticasone propionate on bacterial recognition receptors in COPD macrophages Source: International Congress 2016 – Airway response to infection Year: 2016 Differential effects of budesonide and fluticasone propionate on bronchial epithelial barrier function Source: International Congress 2014 – Novel approaches and evidence for drug development in respiratory diseases Year: 2014 Anti-inflammatory effect of the combination of a long acting β2-agonist (salmeterol) and a corticosteroid (fluticasone propionate) on human airway epithelial cells following staphylococcus aureus virulence factors challenge Source: Eur Respir J 2006; 28: Suppl. 50, 104s Year: 2006 Differential effects of budesonide and fluticasone propionate on expression of lactotransferrin in airway epithelium Source: International Congress 2014 – Novel evidence relating to respiratory treatment development Year: 2014 Anti-inflammatory effect of the combination of a long acting beta2-agonist (salmeterol) and a corticosteroid (fluticasone propionate) on human airway epithelial cells following Staphylococcus aureus infection Source: Eur Respir J 2005; 26: Suppl. 49, 98s Year: 2005 Fluticasone propionate reduces bacterial airway epithelial invasion Source: Eur Respir J 2008; 32: 1283-1288 Year: 2008 Differential effect of fluticasone on Poly(I:C) induced TSLP secretion by bronchial epithelial cells from asthmatic children Source: International Congress 2016 – Mechanisms of disease Year: 2016 Tiotropium and fluticasone inhibit rhinovirus-induced mucin production via multiple mechanisms in differentiated airway epithelial cells Source: Virtual Congress 2020 – Host-microbe interactions and their influence on lung disease onset and severity Year: 2020 Comparison of budesonide and fluticasone propionate on COPD macrophage phagocytosis and killing of bacteria Source: International Congress 2014 – Novel evidence relating to respiratory treatment development Year: 2014 Fluticasone propionate decreases MUC5AC expression on airway epithelial cells induced by rhinovirus infection in the airway Source: Annual Congress 2011 - Experimental modulation of airway inflammation Year: 2011 Effect of clarithromycin on rhinovirus-16 infection in A549 cells Source: Eur Respir J 2006; 27: 12-19 Year: 2006 Effect of roflumilast N-oxide on non-typable haemophilus influenzae (NTHi) interaction with human airway epithelial A549 cells Source: Annual Congress 2011 - Epithelial cell biology Year: 2011 Effect of corticosteroids on epithelial cell response to non-typeable haemophilus influenzae Source: International Congress 2016 – Studies in airway cell biology Year: 2016 Initial interaction of fluticasone propionate with ciliated respiratory epithelium Source: International Congress 2016 – Pulmonary drug delivery Year: 2016 Comparison of fluticasone propionate and budesonide on phagocytosis of common respiratory pathogens in COPD patients Source: Annual Congress 2011 - Immunology and cell biology of asthma and COPD Year: 2011 Rhinovirus infection of human ciliated respiratory epithelial cultures Source: International Congress 2016 – Viral infections in different respiratory conditions: from the bedside to the lab Year: 2016 T regulatory cells: Immunomodulation by budesonide and formoterol on COPD patients Source: International Congress 2015 – Mucosal immunology: what’s new in 2015 Year: 2015 Vitamin D-mediated expression of the antimicrobial peptide hCAP18/LL-37 and killing of non-typeable haemophilus influenzae (NTHi) is reduced after 14 days exposure to TNF-α and IL-1β in primary bronchial epithelial cells (PBEC) Source: International Congress 2015 – The multiple faces of host defense Year: 2015 Increased uptake of haemophilus influenzae by primary airway epithelial cells from COPD patients Source: International Congress 2016 – New signalling pathways in COPD Year: 2016